Warning letter
Northridge Hospital Medical Cent: warning letter of Dec 13, 2016
FDA warning letter 506447 · Los Angeles District Office
Key facts
| Reference number | 506447 |
|---|---|
| Company | Northridge Hospital Medical Cent |
| Subject | Drug/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Dec 13, 2016 |
| Posted date | Jan 31, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| Inspection city | Northridge |
| Inspection ZIP | 91325 |
| Inspection start date | Feb 16, 2016 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: